Discover the Latest Advances in Variant Classification and Interpretation Tools at Golden Helix's Booth at AMP 2024
Join Golden Helix at the Association for Molecular Pathology (AMP) 2024 conference in Vancouver, BC, and explore the forefront of molecular pathology and cancer genomics. This premier event gathers leading researchers, clinicians, and industry experts to share insights on cutting-edge topics in precision oncology and molecular diagnostics.
At Golden Helix's booth (#1511), you'll have the opportunity to learn more about our comprehensive suite of genetic analysis tools. We’re excited to showcase our latest advancements in cancer capabilities, including VarSeq’s enhanced support for cancer and inherited disease research. VarSeq is now powering deeper insights into complex cancer cases with capabilities designed to streamline variant interpretation in oncology, including a focus on hematological cancers through our CancerKB knowledgebase. Learn more about how our tools enable precise cancer variant classification and interpretation, supporting clinical and research efforts alike.
Our pharmacogenomics solution, VSPGx, continues to push the boundaries of PGx analysis. With enhanced capabilities, including the CYP2D6 star allele caller, CypCall, and expanded reporting for star alleles like those in the HLA gene, VarSeq provides seamless integration of PGx into your workflows.
Stop by our booth to experience live demos of our software, explore the newest features, and discuss how our tools can revolutionize your cancer research and molecular pathology workflows. Plus, by visiting our booth for a demo, you'll receive one of our exclusive, limited-edition t-shirts designed just for AMP 2024 attendees!
Don’t miss this opportunity to discover the latest in variant analysis tools and engage with our expert team at AMP 2024. We can't wait to see you in Vancouver!
Find us in Booth #1511
Come explore our exciting product demos and meet our team at Booth #1511. Don’t forget to grab a brand-new t-shirt when you attend a demo. See you in Vancouver!
Demo Schedule
Don't miss out on the chance to experience our advanced software solutions in action! Our expert Field Application Scientist team will be leading short software demos throughout the conference exhibition at our booth. Stop by to see how our powerful and user-friendly tools can help take your genomic analysis and interpretation to the next level.
- Thursday, November 21:
- 12:00 - Somatic NGS Workflow with VarSeq - Streamlining Tertiary Analysis with Oncogenicity Classifier and CancerKB
- 12:30 - Assessing Blood Cancer Samples with Golden Helix CancerKB 4.0
- 1:00 - NGS Enterprise Capabilities - Automation, Warehousing, Continuous Improvement
- 3:45 - Carrier Status Analysis in VarSeq
- 4:30 - PGx: Pharmacogenomics Workflow
- 6:30 - VarSeq Dx: Using the VarSeq Suite as a Medical Device Under IVDR
- Friday, November 22:
- 9:30 - NGS Enterprise Capabilities - Automation, Warehousing, Continuous Improvement
- 12:00 - Assessing Blood Cancer Samples with Golden Helix CancerKB 4.0
- 12:30 - Somatic NGS Workflow with VarSeq - Streamlining Tertiary Analysis with Oncogenicity Classifier and CancerKB
- 1:00 - PGx: Pharmacogenomics Workflow
- 3:10 - VarSeq Dx: Using the VarSeq Suite as a Medical Device Under IVDR
- 3:40 - Carrier Status Analysis in VarSeq
- Saturday, November 23:
- 9:30 - Carrier Status Analysis in VarSeq
- 10:00 - Somatic NGS Workflow with VarSeq - Streamlining Tertiary Analysis with Oncogenicity Classifier and CancerKB
- 12:00 - Assessing Blood Cancer Samples with Golden Helix CancerKB 4.0
- 12:40 - 1:10 Innovation Spotlight Talk (Stage #2): Golden Helix: Advancing Precision Oncology with Automated Genomic Solutions
Innovation Spotlight Talk
Golden Helix: Advancing Precision Oncology with Automated Genomic Solutions
Saturday, November 23, 12:40 - 1:10, Stage 2
Presented by: Gabe Rudy, Vice President of Product & Engineering
Join us for an in-depth session on how we are revolutionizing cancer genomics through automation and comprehensive analysis. Our session will highlight the latest advancements in utilizing VarSeq to adhere to AMP guidelines for cancer variant analysis and clinical reporting. Discover how our automation capabilities streamline the interpretation of complex genomic signatures and allow for more efficient and scalable laboratory operations. We will be showcasing updates to CancerKB, which offers report-ready interpretations with multi-biomarker insights, tumor-specific therapies, and clinically significant results. Additionally, learn about our innovative approaches to methylation analysis, further enhancing precision in cancer diagnostics. This session is a must-attend for those looking to stay at the forefront of molecular oncology, leveraging cutting-edge tools that transform genomic data into actionable clinical insights.